HIV PREVENTION DRUG COULD REDUCE CASES GLOBALLY BUT USAID CUTS PREVENT ACCESS, SAY EXPERTS

Injectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide Sign up for the Breaking News US newsletter email New innovations in HIV prevention could dramatically reduce the… One year ago, the World Health Organization recommended that governments around the world prioritize expanded access to lenacapavir, an injectable version of the HIV prevention medication PrEP that requires only two…

World news | The Guardian reports that injectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide Sign up for the Breaking News US newsletter email New innovations in HIV prevention could dramatically reduce the…

The report adds: One year ago, the World Health Organization recommended that governments around the world prioritize expanded access to lenacapavir, an injectable version of the HIV prevention medication PrEP that requires only two…

PrEP, which also comes in the form of daily oral medications and bimonthly injections, is 99% effective in preventing sexually transmitted HIV for people who take it consistently.

This report is covered across the current DAMMNEWS feeds. Health reports can affect personal decisions, so the source, study size and official guidance matter more than a short headline alone.

This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.

DAMMNEWS RSS BRIEFING — generated locally from the available World news | The Guardian headline and RSS excerpt. It is not a summary of the full source article.